Document:

<Page>

Exhibit 10.29

                              COMMISSION AGREEMENT

         THIS COMMISSION AGREEMENT ("Agreement") is entered as of this 17th day
of December, 2001, by and between e-MedSoft.com dba Med Diversified ("MED"), on
the one part, and Societe Financiere du Seujet Limited and/or its designee
("SFSL") on the other part. MED and SFSL may hereinafter be collectively
referred to as the "Parties".

         The Parties hereto hereby irrevocably and unconditionally agree to the
following:

         1.       As and for consideration to SFSL and its commission partners
                  in connection with the US $40M funding (the "US$40M Funding")
                  pursuant to the Short Form Convertible Debenture dated
                  December 28, 2001 (a copy of which is attached hereto as
                  Exhibit "A" and incorporated herein by reference), MED shall
                  pay a cash commission in the amount of Six Hundred Eighty
                  Thousand Dollars ($680,000) to SFSL and/or its designee (the
                  "US$680,000 Cash Commission") via wire transfer to the account
                  identified on Exhibit "B" attached hereto and incorporated
                  herein by reference, to be received by SFSL on or before
                  December 26th, 2001. MED hereby further agrees to issue and
                  deliver through the law offices of Manatt Phelps, Los Angeles,
                  California, and to a representative as directed by SFSL, the
                  2,000,000 free-trading shares of MED, as previously agreed to
                  pursuant to the May 30, 2001 and November 28, 2001 agreements,
                  which receipt for the original restricted share certificates
                  was provided by MED to SFSL on December 17, 2001 (the "Free
                  Trading Shares").

         2.       MED hereby irrevocably and unconditionally agrees that it
                  shall receive no cash proceeds unless and until SFSL has
                  received all of the above mentioned consideration.

         3.       This Agreement shall be binding upon the Parties hereto and
                  their heirs, executors, successors and assigns.

         4.       This Agreement may not be modified, amended, altered or
                  supplemented except upon the execution of a written agreement,
                  executed by each of the Parties hereto.

         5.       If any provision of this Agreement is held to be invalid, void
                  or unenforceable as a matter of law, the remaining provisions
                  hereof shall nevertheless continue in full force and effect.

                                Page One of Two
<Page>

         6.       This Agreement shall be governed by and construed in
                  accordance with Swiss laws.

         7.       This Agreement may be executed in separate counterparts, by
                  original and/or facsimile copy, each of which shall be deemed
                  an original, but all of which together shall constitute one
                  and the same instrument.

ACKNOWLEDGED, AGREED TO AND ACCEPTED THIS 17th DAY OF DEC., 2001.

SOCIETE FINANCIERE                   E-MEDSOFT.COM DBA
DU SEUJET LIMITED                    MED DIVERSIFIED

By:                                  By:
    __________________________           __________________________________
    Riccardo Mortara                     Frank P. Magliochetti, Jr.
    Authorized Signatory                 Its President, Chief Executive Officer
                                         And Vice Chairman
                                         Authorized Signatory

                                Page Two of Two
<Page>

                                 EXHIBIT "A" TO
                              COMMISSION AGREEMENT

US $40M CONVERTIBLE DEBENTURE
TO BE ATTACHED
<Page>

                                 EXHIBIT "B" TO
                              COMMISSION AGREEMENT

WIRE INSTRUCTIONS FOR PAYMENT OF $680,000 CASH COMMISSION TO SFSL TO BE RECEIVED
ON OR BEFORE DECEMBER 26th, 2001:

Northern Trust International Banking Corp. N.Y.

ABA No.:                            026001122
Favor:                              Sofipriv
Account No.:                        108258-20230
For further credit to:              Societe Financiere du Seujet Limited<Page>

                                                                   Exhibit 10.30

                              COMMISSION AGREEMENT

         THIS COMMISSION AGREEMENT ("Agreement") is entered as of this 17th day
of December, 2001, by and between e-MedSoft.com dba Med Diversified and its
respective affiliates, associates, assigns and successors-in-interest
(collectively "MED"), on the one part, and Societe Financiere du Seujet Limited
and/or its designee (collectively "SFSL") on the other part. MED and SFSL may
hereinafter be collectively referred to as the "Parties".

         The Parties hereto hereby irrevocably and unconditionally agree to the
following:

         1.       SFSL has introduced to MED the following individuals and
                  entities, including each of their respective affiliates,
                  associates, assigns and successors-in-interest: (i)
                  Bridgewater Capital Corporation ("Bridgewater"); (ii) Urban
                  Smedsby ("Smedsby"); (iii) Levinson Capital Corporation
                  ("Levinson Capital"); and (iv) Samuel Levinson ("Levinson").
                  Bridgewater, Smedsby, Levinson Capital and Levinson may
                  hereinafter be collectively referred to as the "SFSL Sources".

         2.       SFSL has represented to MED that the SFSL Sources may have an
                  interest in certain investments and/or transactions relating
                  to MED.

         3.       In the event any of the SFSL Sources consummate any type of
                  investment and/or transaction with MED, SFSL and/or its
                  designee shall, for its introductions and services to MED, be
                  compensated by MED in an amount equal to six percent (6%) of
                  the gross amount of any such investment in cash and concurrent
                  with the closing (the "SFSL Fee").

         4.       MED hereby irrevocably and unconditionally agrees that no
                  transactions with any SFSL Sources are to be consummated
                  unless and until MED has received written consent and approval
                  from SFSL.

         5.       MED hereby irrevocably and unconditionally agrees not to
                  circumvent SFSL in connection with any matter or transaction
                  involving any of the SFSL Sources. MED further irrevocably and
                  unconditionally agrees that such circumvention will cause
                  irreparable harm and damage to SFSL, in an amount to be
                  determined by law.

         6.       MED hereby irrevocably and unconditionally agrees that this
                  Agreement shall be extended to and include any transaction MED
                  on the one part, and any SFSL. Source on the other part, may
                  enter into in the future, and SFSL shall be compensated by MED
                  on any such other transaction in an amount as agreed upon, in
                  writing between MED and SFSL, on a deal-by-deal basis.

                                Page One of Two
<Page>

         7.       This Agreement shall be binding upon the Parties hereto and
                  their heirs, executors, successors and assigns for a period of
                  three (3) years from the date hereof.

         8.       This Agreement may not be modified, amended, altered or
                  supplemented except upon the execution of a written agreement,
                  executed by each of the Parties hereto.

         9.       If any provision of this Agreement is held to be invalid, void
                  or unenforceable as a matter of law, the remaining provisions
                  hereof shall nevertheless continue in full force and effect.

         10.      This Agreement shall be governed by and construed in
                  accordance with Swiss laws.

         11.      This Agreement may be executed in separate counterparts, by
                  original and/or facsimile copy, each of which shall be deemed
                  an original, but all of which together shall constitute one
                  and the same instrument.

         IN WITNESS WHEREOF, the Parties have caused this Agreement to be
executed on the day and year first above written.

SOCIETE FINANCIERE                             E-MEDSOFT.COM DBA MED
DU SEUJET LIMITED                              DIVERSIFIED

By: __________________________________     By: _________________________________
    Riccardo Mortara                           Frank P. Magliochetti, Jr.
    Authorized Signatory                       Its President, Chief Executive
                                               Officer And Vice Chairman
                                               Authorized Signatory

                                Page Two of Two<Page>

                                                                   Exhibit 10.31

                              COMMISSION AGREEMENT

         THIS COMMISSION AGREEMENT ("Agreement") is entered as of this 17th day
of December, 2001, by and between e-MedSoft.com dba Med Diversified ("MED"), on
the one part, and Societe Financiere du Seujet Limited and/or its designee
("SFSL") on the other part. MED and SFSL may hereinafter be collectively
referred to as the "Parties".

         The Parties hereto hereby irrevocably and unconditionally agree to the
following:

         1.       As and for consideration to SFSL and its commission partners
                  in connection with the US$45M funding (the "US$45M Funding"),
                  with a minimum US$30M funding by 5:00 p.m. EST, December 28,
                  2001 (the "US$30M Funding"), pursuant to the Short Form
                  Debenture dated December 28, 2001 (a copy of which is attached
                  hereto as Exhibit "A" and incorporated herein by reference),
                  concurrent with the closing of such US$30M Funding MED shall:
                  (i) pay a cash commission to SFSL and/or its designee in the
                  amount of Four Million Dollars ($4,000,000), payable Two
                  Million Seven Hundred Thousand Dollars ($2,700,000) concurrent
                  with the US$30M Funding (the "$2,700,000 Cash Commission"),
                  and the balance of One Million Three Hundred Thousand Dollars
                  ($1,300,000) payable concurrent with the funding of the US$15M
                  Funding defined hereinbelow, or payable on a pro rata basis
                  (the $1,300,000 Cash Commission"); (ii) issue ten million
                  (10,000,000) shares of MED to SFSL and/or its designee (the
                  "Collateral Shares") that are the same class and par value of
                  shares as those currently traded on the American Stock
                  Exchange - SFSL has the unilateral right to purchase
                  bondholder position for the conversion rights of the
                  10,000,000 Collateral Shares at $3.00 per share; (iii) issue
                  three million (3,000,000) shares of MED to SFSL and/or its
                  designee subject to 50,000 shares per day selling restrictions
                  (the "Bonus Shares"); (iv) issue two million (2,000,000)
                  warrants of MED at $4.20 per share to SFSL and/or its designee
                  (the "Bonus Warrants").

         2.       The Parties hereto irrevocably and unconditionally agree that
                  the $2,700,000 Cash Commission, the Collateral Shares, the
                  Bonus Shares and the Bonus Warrants are to be received by
                  escrow holder and approved by SFSL prior to the closing, and
                  distributed as directed by SFSL concurrent with the US$30M
                  Funding. The balance of five million (5,000,000) Collateral
                  Shares and the balance of the $1,300,000 Cash Commission shall
                  be paid and issued to SFSL and/or its designee concurrent with
                  the additional US$15M funding or any portion thereof (the
                  "US$15M Additional Funding"), subject to the terms and
                  conditions of the US$30M Debenture attached hereto.

                                Page One of Two
<Page>

                  In any event, MED hereby irrevocably and unconditionally
                  agrees to accept the US$15M Additional Funding out of the
                  first monies raised on the bond financing program between SFSL
                  and MED, or MED shall credit SFSL said balance of the funding
                  through the Bridgewater Capital Corporation sources, i.e.,
                  Levinson Capital, Samuel Levinson, or their respective
                  affiliates, associates and assigns. The Parties may agree to
                  execute two (2) separate debentures: one for US$30M and one
                  for US$15M, in exchange for a single US$45M Debenture.

         3.       MED hereby irrevocably and unconditionally agrees that it
                  shall receive no cash proceeds unless and until SFSL has
                  received all of the above mentioned consideration.

         4.       This Agreement shall be binding upon the Parties hereto and
                  their heirs, executors, successors and assigns.

         5.       This Agreement may not be modified, amended, altered or
                  supplemented except upon the execution of a written agreement,
                  executed by each of the Parties hereto.

         6.       If any provision of this Agreement is held to be invalid, void
                  or unenforceable as a matter of law, the remaining provisions
                  hereof shall nevertheless continue in full force and effect.

         7.       This Agreement shall be governed by and construed in
                  accordance with Swiss laws.

         8.       This Agreement may be executed in separate counterparts, by
                  original and/or facsimile copy, each of which shall be deemed
                  an original, but all of which together shall constitute one
                  and the same instrument.

ACKNOWLEDGED, AGREED TO AND ACCEPTED THIS 17th DAY OF DEC., 2001.

SOCIETE FINANCIERE                             E-MEDSOFT.COM DBA MED
DU SEUJET LIMITED                              DIVERSIFIED

By: __________________________________     By: _________________________________
    Riccardo Mortara                           Frank P. Magliochetti, Jr.
    Authorized Signatory                       Its President, Chief Executive
                                               Officer And Vice Chairman
                                               Authorized Signatory

                                Page Two of Two

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00044-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00044-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00044-of-00352.parquet"}]]